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Abstract
We report on the synthesis of water-soluble gold nanoclusters capped with polyethylene glycol
(PEG)-based ligands and further functionalized with folic acid for speciﬁc cellular uptake. The
dihydrolipoic acid-PEG-based ligands terminated with –OMe, –NH2 and –COOH functional
groups are produced and used for surface passivation of Au nanoclusters (NCs) with
diameters<2 nm. The produced sub 2 nm Au NCs possess long-shelf life and are stable in
physiologically relevant environments (temperature and pH), are paramagnetic and
biocompatible. The paramagnetism of Au NCs in solution is also reported. The functional groups
on the capping ligands are used for direct conjugation of targeting molecules onto Au NCs
without the need for post synthesis modiﬁcation. Folic acid (FA) is attached via an amide group
and effectively target cells expressing the folate receptor. The combination of targeting ability,
biocompatibility and paramagnetism in FA-functionalized Au NCs is of relevance for their
exploitation in nanomedicine for targeted imaging.
Supplementary material for this article is available online
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Over the past decade, applications for colloidal nanoparticles
have emerged in bioimaging and nanomedicine, with research
efforts focusing on their formation and improving the stability
in aqueous solutions [1–3]. The optical and electronic prop-
erties of Au nanoparticles change when their diameter is
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smaller than 2 nm, and they are referred to as nanoclusters
(NCs). Recent progress in the ﬁeld has led to the emergence
of ultra-small metal nanoclusters, including gold nanoclusters
(Au NCs) [4], which exhibit discrete, molecule-like energy
levels, tuneable optical properties and are biocompatible
[5, 6], making them promising candidates for a range of
applications, from bioimaging [7] to biosensing [8] and cat-
alysis [9].
A pathway for the generation of Au NCs in aqueous
solution was developed by Susumu et al [10] and follows the
Brust-Schiffrin method using lipoic acid (LA) esteriﬁed to
polyethylene glycol (PEG) as capping ligands. PEG- and LA-
PEG-molecules have been successfully used for water solu-
bilization and biological compatibility in a range of nano-
materials [11], including semiconductor quantum dots
[12, 13] and metal nanoparticles [13, 14]. The incorporation
of amino- or carboxyl-termini onto the PEG chain allows
further modiﬁcation including the attachment of targeting
ligands, such as peptides, small proteins, and anti-
bodies [11, 13].
In recent years, Au NCs have been functionalized for
targeted therapy and bioimaging [15, 16], with particular
interest in functionalization with folic acid (FA) for targeting
to folate receptors, which are overexpressed in breast, colon,
rectal and prostate cancer cells [17]. The targeting ability of
FA has been previously demonstrated for iron oxide nano-
particles (NPs) [18], upconverting rare earth nanoparticles
[19] and Au NPs [15, 20, 21]. Functionalization of Au NCs
with targeting molecules remains challenging, but has been
achieved for nanoparticles with gold core diameters of
2–6 nm using polymeric linkers [15], via conjugation to
bovine serum albumin-stabilized particles [16]. Direct
attachment of FA was demonstrated only for larger particles
[22]. Indeed, direct attachment of FA onto NCs would be
beneﬁcial to avoid signiﬁcant increases in the overall size and
hence properties of the Au NCs, however, to date, this has not
been demonstrated.
Here we describe the synthesis, chemical and physical
characterization, stability and cell targeting abilities of col-
loidal, water soluble Au NCs with core diameters from 1.7 to
2.2 nm. The effects of ligand length, terminal functional
group and the ratio of reactants on morphological, optical and
magnetic properties of Au NCs are also reported. For direct
attachment of FA, LA-PEG-based capping ligands terminated
with –NH2 were used. The stability of FA-functionalized NCs
has been explored under physiologically relevant conditions
and the cytotoxicity has been assessed in vitro. The targeting
ability of FA-Au NCs has been conﬁrmed with FA receptor
expressing cancer cells.
We have synthesized LA-PEG200 and LA-PEG400 cap-
ping ligands with amine (LNH2), methoxy (LOMe) and car-
boxylic acid (LCOOH) terminal functional groups
(ﬁgure 1(a)) to produce aqueous colloidal Au NC solutions.
Brieﬂy, chloroauric acid was used as a source of gold, mixed
with ligands under alkaline conditions (pH∼11) in deio-
nized water and reduced using NaBH4. We have examined
the effect of different molar ratios of Au:Ligand (from 1:0.2
to 1:10) and Au:NaBH4 on the size and colloidal stability of
produced AuNCs. We found that with increasing the Au:
ligand ratio from 1:1 to 1:5, the average diameter decreases
from 1.9±0.3 nm to 1.7±0.3 nm (supplementary infor-
mation S1 is available online at stacks.iop.org/NANO/30/
505102/mmedia). The ratio of Au:Ligand of 1:3, Au:redu-
cing agent of 1:2 and aging time of 20 h produced AuNCs
with sub 2 nm sizes and their colloidal solutions demonstrated
long-shelf life and have narrow size distribution. Puriﬁcation
of the NCs was achieved by centrifugation and ﬁltration
(molecular weight cut-off 10 kDa), producing a concentrated
brown solution. The stability of these AuNCs was conﬁrmed
against physiologically relevant conditions of pH=3.0–10.0
and temperatures T=40 °C and 50 °C. Exposure of the
AuNC solution to different pH and/or T, did not induce any
noticeable changes to their optical and morphological prop-
erties, as assessed by UV–vis and TEM, respectively (see
supplementary information S2).
HR TEM analysis revealed that Au NCs capped with
LNH2 with an Au:ligand ratio of 1:3 possessed an average
diameter dAuNP =1.8±0.4 nm; the crystalline structure of
PEG-Au NCs can be clearly seen in ﬁgure 1(b), with an inter-
plane distance of 2.34 Å, which corresponds to the gold face
centred cubic (FCC) structure phase of (111) [23]. Dark ﬁeld
TEM studies revealed the presence of a thick carbon-based
amorphous layer surrounding the nanocrystal: the non-uni-
form depth of the amorphous layer and the interparticle dis-
tance of2 nm suggests that the LA-PEG200 ligands are not
closely packed and have signiﬁcant ﬂexibility to re-orientate
(see supplementary information, S1). Their position is ran-
dom and the density of the ligand shell is such that ligand
Figure 1. (a) Cartoon of an Au nanocluster capped with DHLA-PEG
ligands terminated with different functional groups. (b) TEM and
HR TEM images of Au NC capped with LA-PEG200-based ligands
with NH2 functional ending group.
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interlocking between neighbouring nanocrystals is possible
[24]. We note that the NCs can be prepared with PEG-based
ligands of different length, from PEG200 to PEG2000
(approximate length of stretched molecules is 3 nm and
10 nm, respectively). The average Au core diameter of the
NCs formed is not affected by either the length of the polymer
chain, nor by the type of the terminal group (–NH2, –COOH,
–OMe) (see supplementary information, S1).
The 1H-NMR reported in ﬁgure 2(a) shows the com-
parison of the relevant chemical shifts between the synthe-
sized ligand and the ligand attached to the surface.
Broadening of the signal is observed, as expected due to faster
relaxation rates resulting from slower tumbling of the NP, but
also could result from the presence of paramagnetic NCs.
Indeed, theoretical work predicts that Au NPs with
sizes<2 nm are expected to have paramagnetic properties
and these were conﬁrmed for the NC ﬁlms [25]. We experi-
mentally observe magnetism in the Au NC ﬁlms by the
measurement of magnetization and in the Au NC solutions by
shortening of the proton relaxation time, T1.
Our magnetic studies using a superconducting quantum
interference device (SQUID) on the Au NPs with sizes 1.8
and 2.2 nm show that at low temperatures (T<50 K) the
nanoparticles are paramagnetic and the 1.8 nm NCs possess
magnetic susceptibility which gradually decreases from 2 K
(7.16×10−6 emu/gOe versus 5.33×10−6 emu/gOe) to
50 K (0.44×10−6 emu/gOe versus 0.15×10−6 emu/gOe)
(ﬁgure 2(b) and supplementary information, S1). For Au NCs
with diameter of 1.8 nm the paramagnetic properties are
observable up to room temperature.
In our NMR studies, we observed signiﬁcant shortening
of the longitudinal relaxation time, T1, for protons in the
capping ligands of Au NCs compared to that for protons in
the ligand only. We note that the biggest difference is
observed for the protons in the immediate proximity of the
NC core (T1 decreases from 1.61 to 0.64 s), as was shown
previously for paramagnetic quantum dots [26] (see also
supplementary information, S1). The observation of mag-
netism in AuNCs is of potential interest for their application
in magnetic resonance imaging. Combined magnetism and
targeting of the NCs could be used for development of novel
diagnostic and therapeutic approaches. This potential devel-
opment requires further detailed investigation.
FA was attached to LA-PEG ligands by a direct coupling
reaction with LA-PEG-NH2 in the presence of the standard
peptide coupling reagents N-(3-dimethylaminopropyl)-N′-
ethylcarbodiimide (EDC) and N-hydroxysuccinimide (NHS)
(ﬁgure 3(a) and supplementary information, S2). The struc-
ture of the ligand shown in the ﬁgure 3(a) illustrates one
molecule of lipoic acid (LA) covalently attached to one
molecule of PEG and the amine at the terminating end of the
LA-PEG coupled with one molecule of folic acid. The EDC
and NHS were used to activate the available carboxyl groups
of FA for coupling to the primary amine of LA-PEG-NH2.
We note that this method is non-regioselective and the reac-
tion occurs with either of the FA carboxylates. Successful
attachment of FA was conﬁrmed by mass ESI micro TOF
spectroscopy, where the negative ion peak for the species is
seen at 802.2991m/z (see supplementary information S3).
The LA-PEG-FA produced was used to functionalize Au
NCs following the same procedure employed for LA-PEG-
capped Au NCs. The FA-ligands provide efﬁcient capping of
the Au NCs and do not dramatically affect the morphology
nor the colloidal stability of the nanoclusters. The dynamic
light scattering (DLS) measurements show that the hydro-
dynamic size of the NCs is increased following functionali-
zation with the FA, from 4.8±1.3 nm to 6.5±1.6 nm
(ﬁgure 3(b)). The successful attachment is also supported by
UV/Vis studies (ﬁgure 3(c)), where an absorption band at
∼370 nm characteristic for FA [27] is observed for FA-Au
NC, but not for Au NCs only. We note, that the synthesis of
the targeted ligand is performed with FA the limiting reagent
with respect to LA-PEG and any excess of reagents and
starting materials is removed during puriﬁcation steps, prior
to using LA-PEG-FA ligand for the synthesis of the Au NCs.
Our HR TEM studies revealed the presence of Au NCs
with an average diameter of dAuNP =1.6±0.3 nm
(ﬁgure 3(d)). An increase in interparticle spacing (>4 nm)
Figure 2. (a) Representative 1H-NMR spectra of the ligand alone
(black) and attached to the surface of a Au NC (green). Inset shows
chemical structure of the ligand with assigned protons. (b) SQUID
measurements of magnetic susceptibility and magnetization (inset)
for Au NCs with diameters of 1.8 and 2.2 nm.
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compared to non functionalized NCs, is also observed in the
bright- and dark-ﬁeld TEM images (Inset in ﬁgure 3(d) and
supplementary information S1, ﬁgure S2), indicating the
presence of longer ligands consistent with the presence of FA
on the NCs. This interpretation supports our observation of
larger hydrodynamic diameter for FA-Au NCs compared to
non-targeted Au NCs in our DLS measurements.
The 1H-NMR spectra of FA-Au NCs are shown in
ﬁgure 4. The FA-Au NCs spectrum contains FA-related peaks
at 8.63, 7.68 and 6.84 ppm, conﬁrming successful passivation
of the Au NCs with folic acid functionalized capping ligands.
The long-term stability of both targeted and non-targeted Au
NCs was investigated with respect to optical and morpholo-
gical properties. UV–vis spectroscopy, NMR and TEM stu-
dies were performed at different times over a period of at least
18 months and revealed no changes for the NCs properties
(solutions were stored at 4 °C). The FA-Au NCs were found
to be stable at pH values between 7 and 11, and at tem-
peratures up to T=50 °C. The long-term stability observed
for our AuNCs and FA-Au NCs at physiologically relevant
pH and temperature are promising for their further applica-
tions (see supplementary information S2).
To explore the effect of the Au NCs on cell viability, we
selected three human-derived carcinoma cell lines: MCF-7
and MDA-MB-231 breast cancer cells, and HCT-116 colon
cancer cells. Cell viability was assessed using the 3-(4,5-
dimethylthizol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
assay. Cells were seeded in 96 well plates and allowed 24 h to
adhere, before exposure to Au NCs and FA-Au NCs
(0.5 mM; 72 h). No noticeable toxicity was observed over
all the range of treatment concentrations (ﬁgures 5(a), (b) and
supplementary information, S4). A small decrease in viable
cell population of ∼25% was observed for both agents at very
high concentrations (0.1–0.5 mM).
In order to conﬁrm FA targeting of Au NC, inductively
coupled plasma mass spectrometry (ICP-MS) was used to
estimate cellular uptake of NCs by the folic acid receptor
expressing (FR+)human breast cancer cell line MDA-MB-
231. The MDA-MB-231 cell line has the greatest abundance
of folic acid receptors alpha (FRα), with 369±6 fg/cell,
(FAα, 38 kDa, 5.8×106±9.5×104/cell) while the MCF-
7 cell line has 209±5 fg/cell (3.3×106±7.9×104/cell)
[28] and the HCT-116 expresses the lowest levels [16]. Cells
were exposed to FA-Au NCs and Au NCs for 24 h prior to
cell harvesting. The cellular uptake of both types of Au NCs
by MDA-MB-231 cells is shown in ﬁgure 5(c) as weight ratio
between the amount of gold uptaken and that used for cell
treatment. Cell uptake assessment by ICP MS on FRα-
negative A549, human lung cancer cell line, found compar-
able uptake of non-targeted and FA-functionalised Au NC,
with only ∼20% greater amount of Au detected in A549 cells
exposed to FA-functionalised NCs. This increase is sig-
niﬁcantly lower compared to FR+MDA-MB-231 cells,
where FA-targeted Au NCs are internalized by the cells in
greater quantities (∼2 fold enhancement) compared to non-
targeted Au NCs (see supplementary information S4). Com-
parable increases in cell internalization of NP have previously
been reported for FA-conjugated Fe3O4 [29].
Figure 3. (a) Chemical structure of folic acid conjugated ligand. (b)
Hydrodynamic diameter of the Au NCs and FA-Au NCs measured
by DLS. (c) UV–vis spectra of Au NC (black), Au NC-FA (red) and
FA (blue). (d) Representative TEM and (inset) dark ﬁeld images of
FA conjugated Au NCs.
Figure 4. 1H-NMR spectra of (a) FA-Au NCs and (b) Au NCs,
evidencing peaks of aromatic protons on the folic acid moiety
indicated by arrows. Observed artifact at ∼4.7 ppm is due to
excitation sculpting for water peak suppression.
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In our conjugation method, there is no regioselectivity
towards the α- or γ-carboxylic groups in the glutamic acid
moiety of the FA. However, the chosen methodology enables
readily accessible coupling that is known to produce up to
90% of γ-conjugates [30]. Further puriﬁcation of γ-con-
jugates or direct synthesis of γ-conjugated FA-derivatives
[31, 32] could offer improvements in targeting due to their
higher afﬁnity to folate receptors [31], and beneﬁcial inter-
actions of the free α-carboxylic group with residues within
the receptor [33].
In conclusion, we have demonstrated successful synth-
esis of sub 2 nm diameter Au NCs and their successful pas-
sivation with FA-PEG-LA ligands. The FA-Au NCs are
efﬁciently targeted to FA-overexpressing cancer cells, such as
MDA-MB-231. Combined low cytotoxicity and enhanced
cellular uptake are of interest for exploitation of these NCs in
nanomedicine. Furthermore, the observed paramagnetism
could herald exciting opportunities for targeted MRI. The
imaging and therapy prospects of these NCs therefore merit
future studies in vivo.
Experimental section
Experimental techniques
All reagents were obtained from Sigma-Aldrich Co. Ltd and
were used without further puriﬁcation. TLC analysis of
reaction mixtures was performed using Merck Kieselgel 60
F254 plates; visualization was carried out by irradiation with a
UV lamp (254 nm) and staining with phosphomolybdic acid
or permanganate solution. 1H and 13C NMR spectra were
recorded at ambient temperature with Bruker DPX 300,
Bruker AV400, Bruker AV(III)400 or Bruker AV(III)500
spectrometers and were referenced to residual 1H and 13C
signals of the deuterated solvents, respectively (δH 7.26, δC
77.00 for chloroform). The NMR spectra of NCs in water
solution were collected at 600MHz on a Bruker Avance III
spectrometer at 298 K in H2O:D2O (1:9). For transmission
electron microscopy (TEM) studies, the nanoparticles were
deposited on a graphene oxide-coated grid and TEM images
were recorded on a JEOL 2100 F FEGTEM microscope
operating at 200 kV. The optical properties of Au NCs were
measured in solution in quartz cuvettes with an Agilent Cary
100 UV–vis spectrometer at 25 °C. A commercial Quantum
Design MPMS-XL5 SQUID magnetometer was used for the
magnetic characterization of frozen solution samples frozen in
quartz tubes with negligible diamagnetic contribution. Vari-
able-temperature (1.8–20 K) and ﬁeld-dependent (0–5 T)
magnetization measurements were carried out using the
reciprocating sample option with a sensitivity of
5×10− 9 emu.
Synthesis of Au NCs with LA-PEG400-R
For the synthesis of the capping ligands, the procedure from
the [34] was adopted. LA-PEG400-R (30 μmol) was dissolved
in deionized water (20 ml) containing sodium hydroxide
(50 μl, 2 M). Chloroauric acid (10 μl, 1 M in water,
0.01 mmol) was added and stirred gently for 5 min. Sodium
borohydride (400 μl, 50 mM in water) was added dropwise
and the resulting solution was moderately stirred overnight at
room temperature. Crude Au NCs solution was centrifuged
through AMICON column ﬁlters (10 kDaMW cut-off, 1
cycles @ 4000 g for 20 min), with the nanoparticles being
collected over the membrane and dispersed in water. The
resulting solution was stored at 4 °C.
Synthesis of FA-PEG-LA
For FA conjugation, 10 ml dimethyl sulfoxide (DMSO) was
loaded in a 50 ml round bottom ﬂask. FA (0.16 g, 0.36 mmol)
was added into the ﬂask and stirred until totally dissolved. N-
(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydro-
chloride (0.104 g, 0.544 mmol) and N-hydroxysuccinimide
(64 mg, 0.544 mmol) were added to the reaction and stirred
Figure 5.MTT assays results of PEG200-AuNCs and FA-AuNCs on
(a) MCF-7 and (b) HCT-116. Results are shown ±SD for n=9. (c)
Cellular uptake of FA-Au NCs and PEG-Au NC by FA over-
expressing MDA-MB-231 cells following 24 h exposure. The uptake
was quantiﬁed by ICP-MS.
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for 20 h in the dark. LA-PEG200-NH2 (0.4197 g, 1.08 mmol)
was added to the mixture and further stirred for 16 h. The
precipitate formed after the addition of acetone (50 mL) was
collected and dissolved in 40 ml of ethyl acetate (EtOAc). The
organic layer was washed with brine (50 ml, ﬁve times) and
dried over anhydrous sodium sulphate (Na2SO4), con-
centrated under reduced pressure to yield the ﬁnal product
(HRMS expected value for C35H49N9O9S2 [M–H]
− is
802.3022m/z, found 802.2991m/z; see also supplementary
information, S2).
Synthesis of Au NCs functionalized with FA
LA-PEG200-FA (30 μmol) was dissolved in deionized water
(20 ml) containing sodium hydroxide (50 μl, 2 M). Chlor-
oauric acid (10 μl, 1 M, 0.01 mmol) was added and stirred
gently for 5 min. Sodium borohydride solution (400 μl,
50 mM) was added dropwise and moderately stirred overnight
at room temperate to obtain crude Au NCs. The solution
obtained was puriﬁed by centrifugation (three times) using
AMICON ﬁlters with a molecular weight cut-off of 10 kDa at
4000 g for 20 min per run. The resulting solutions were stored
at T=4 °C until further use.
In vitro characterization
For MTT assays, cells were seeded into a 96 well plate at a
density of 3000 cells/well. Cells were allowed 24 h to adhere
prior to treatment. Au NCs were tested at ﬁnal concentrations
between 10 nM and 0.5 mM. Following 72 h exposure of cells
to Au NCs, 50 μl 2 mg ml−1 MTT was added. The plate was
incubated for 2 h. Thereafter, medium and test agent were
aspirated and formazan crystals dissolved in DMSO (150 μl
per well). Absorbance values were read at 550 nm using an
EnVision® Multilabel Plate Reader (PerkinElmer). Cell via-
bility was estimated as percentage absorbance compared to
untreated control cells.
Cellular uptake of Au NPs was assessed using ICP-MS.
The cells were seeded into a six well plate at a density of 105
cells/well and incubated for 24 h. The medium was aspirated
and treatment agent added (2 ml/well) at Au NC concentra-
tion of 10 μM. Following 24 h exposure, the medium was
aspirated and the cells were washed with PBS (3×2 ml) to
remove extracellular Au NCs. Then 16M HNO3 (14 ml) was
added to digest cells for 30 min. The solution was diluted with
deionized water to 5 ml for ICP-MS studies.
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